Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces the FDA clearance of the pocket-sized PICO* system, a single use Negative Pressure Wound Therapy (NPWT) system. PICO* is cleared for use both in a hospital and homecare setting and expands the use of NPWT from the traditional wound care population to include a wider range of patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures.

Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN) today announced the launch of ALLEVYN* Gentle Border Sacrum, a new dressing that incorporates Gentle Border technology and is designed specifically for managing wounds located in the sacral area.

The Advanced Wound Management division of Smith & Nephew, (LSE: SN; NYSE: SNN) today announced the CE Mark approval for PICO*, an effective, single-use, Negative Pressure Wound Therapy (NPWT) system for acute and chronic wounds, high-risk surgical incisions and skin grafts.

Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the first quarter ended 2 April 2011.